[17] Impairment of TP53 signaling is also a feature of other dedifferentiated bone and soft tissue tumors, e.g. in dedifferentiated chondrosarcoma, a notably higher prevalence of TP53 mutations is observed compared to classic chondrosarcoma. This evidence concerns the gene TP53 and soft tissue neoplasm.